checkAd

     193  0 Kommentare Vaccinex Announces Pricing of $9.6 Million Public Offering - Seite 3



    Investor Contact
    John Mullaly
    LifeSci Advisors, LLC
    617-429-3548
    jmullaly@lifesciadvisors.com

    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Vaccinex Announces Pricing of $9.6 Million Public Offering - Seite 3 ROCHESTER, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) - Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through …